Logo image of ATNF

180 LIFE SCIENCES CORP (ATNF) Stock Price, Quote, News and Overview

NASDAQ:ATNF - Nasdaq - US68236V3024 - Common Stock - Currency: USD

1.18  -0.02 (-1.67%)

After market: 1.15 -0.03 (-2.54%)

ATNF Quote, Performance and Key Statistics

180 LIFE SCIENCES CORP

NASDAQ:ATNF (3/7/2025, 8:06:04 PM)

After market: 1.15 -0.03 (-2.54%)

1.18

-0.02 (-1.67%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High17.75
52 Week Low1.1
Market Cap3.75M
Shares3.18M
Float2.60M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-20 2025-03-20/amc
IPO06-07 2017-06-07


ATNF short term performance overview.The bars show the price performance of ATNF in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

ATNF long term performance overview.The bars show the price performance of ATNF in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ATNF is 1.18 USD. In the past month the price decreased by -14.49%. In the past year, price decreased by -66.57%.

180 LIFE SCIENCES CORP / ATNF Daily stock chart

ATNF Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.17 378.30B
AMGN AMGEN INC 16.39 174.51B
GILD GILEAD SCIENCES INC 25.47 146.22B
VRTX VERTEX PHARMACEUTICALS INC 1683.76 125.39B
REGN REGENERON PHARMACEUTICALS 15.5 77.34B
ARGX ARGENX SE - ADR 231.21 36.10B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.66B
ONC BEIGENE LTD-ADR N/A 26.47B
BNTX BIONTECH SE-ADR N/A 26.08B
BIIB BIOGEN INC 9.13 22.01B
NTRA NATERA INC N/A 19.02B
GMAB GENMAB A/S -SP ADR 24.89 15.34B

About ATNF

Company Profile

ATNF logo image 180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California and currently employs 4 full-time employees. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.

Company Info

180 LIFE SCIENCES CORP

3000 El Camino Real, Bldg 4, Ste 200

Palo Alto CALIFORNIA 10019 US

CEO: James N. Woody

Employees: 4

Company Website: https://180lifesciences.com/

Phone: 16505070669

180 LIFE SCIENCES CORP / ATNF FAQ

What is the stock price of 180 LIFE SCIENCES CORP today?

The current stock price of ATNF is 1.18 USD. The price decreased by -1.67% in the last trading session.


What is the ticker symbol for 180 LIFE SCIENCES CORP stock?

The exchange symbol of 180 LIFE SCIENCES CORP is ATNF and it is listed on the Nasdaq exchange.


On which exchange is ATNF stock listed?

ATNF stock is listed on the Nasdaq exchange.


What is 180 LIFE SCIENCES CORP worth?

180 LIFE SCIENCES CORP (ATNF) has a market capitalization of 3.75M USD. This makes ATNF a Nano Cap stock.


How many employees does 180 LIFE SCIENCES CORP have?

180 LIFE SCIENCES CORP (ATNF) currently has 4 employees.


What are the support and resistance levels for 180 LIFE SCIENCES CORP (ATNF) stock?

180 LIFE SCIENCES CORP (ATNF) has a resistance level at 1.27. Check the full technical report for a detailed analysis of ATNF support and resistance levels.


Is 180 LIFE SCIENCES CORP (ATNF) expected to grow?

The Revenue of 180 LIFE SCIENCES CORP (ATNF) is expected to grow by 481.87% in the next year. Check the estimates tab for more information on the ATNF EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy 180 LIFE SCIENCES CORP (ATNF) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does 180 LIFE SCIENCES CORP (ATNF) stock pay dividends?

ATNF does not pay a dividend.


When does 180 LIFE SCIENCES CORP (ATNF) report earnings?

180 LIFE SCIENCES CORP (ATNF) will report earnings on 2025-03-20, after the market close.


What is the Price/Earnings (PE) ratio of 180 LIFE SCIENCES CORP (ATNF)?

180 LIFE SCIENCES CORP (ATNF) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.49).


What is the Short Interest ratio of 180 LIFE SCIENCES CORP (ATNF) stock?

The outstanding short interest for 180 LIFE SCIENCES CORP (ATNF) is 0.85% of its float. Check the ownership tab for more information on the ATNF short interest.


ATNF Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ATNF Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ATNF. ATNF has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ATNF Financial Highlights

Over the last trailing twelve months ATNF reported a non-GAAP Earnings per Share(EPS) of -4.49. The EPS increased by 98.18% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -29.82%
ROE -83.61%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%96.52%
Sales Q2Q%N/A
EPS 1Y (TTM)98.18%
Revenue 1Y (TTM)N/A

ATNF Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to ATNF. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 50% and a revenue growth 481.87% for ATNF


Ownership
Inst Owners16.4%
Ins Owners2.47%
Short Float %0.85%
Short Ratio0.05
Analysts
Analysts82.86
Price TargetN/A
EPS Next Y50%
Revenue Next Year481.87%